NICE backs blood clot combination

06 November 2009

NICE has approved the use of the antiplatelet drug prasugrel in combination with aspirin as an option for preventing blood clots in patients with acute coronary syndromes.

The final guidance, published last week, recommends that patients should be offered pra-sugrel in combination with aspirin if they require treatment for ST-segment-elevation MI.

They should also receive the treatment if they have devel-oped a blood clot blocking a stent while receiving treatment with clopidogrel.

Diabetic patients should also be considered for the combination treatment, NICE has recommended.

Dr Carole Longson, director of NICE's Health Technology Evaluation Centre, said: 'There are a range of heart problems classed as acute coronary syndromes - these have a huge impact on the individuals affected.

'This new guidance recom-mending prasugrel in combina-tion with aspirin will offer an additional treatment option for these specific individuals at risk of blood clots,' Dr Longson added.

Send to a friend

Items with an asterisk * are required

blog comments powered by Disqus

Additional Information


 

Latest jobs Jobs web feed

More General Practice Jobs
 

MIMS Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.


Medical Conferences

Book your place or register your interest for our clinical conferences.